Inhibition of superoxide production and chemotaxis by methotrexate in neutrophils primed by TNF-α or LPS

European Journal of Haematology

Volumn 59, Issue 3, 1997, Pages 142-147

  Okuda, Akiro ^a   Kubota, Masaru ^a   Watanabe, Kenichiro ^a   Sawada, Machiko ^a   Koishi, Seiji ^a   Kataoka, Akihiro ^a   Usami, Ikuya ^a   Lin, Ying Wei ^a   Furusho, Kenshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHEMOATTRACTANT; CHEMOTAXIS INHIBITOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GRANULOCYTE COLONY STIMULATING FACTOR; GUANOSINE; HYPOXANTHINE; INTERLEUKIN 8; METHOTREXATE; PHORBOL 13 ACETATE 12 MYRISTATE; PURINE NUCLEOTIDE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; NEUTROPHIL CHEMOTAXIS; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL;

EID: 0030846246     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb00967.x     Document Type: Article

References (28)

1. KITAGAWA S, YUO A, SOUZA LM, SAITO M, MIURA Y, TAKAKU F. Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Commun 1987: 144: 1143-1146.
2. BOBER LA, GRACE MJ, PUGLIESE SC, et al. The effect of GM-CSF and G-CSF on human neutrophil function. Immunopharmacology 1995: 29: 111-119.
3. LOPEZ AF, WILLIAMSON DJ, GAMBLE JR, et al. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 1986: 78: 1220-1228.
4. YUO A, KITAGAWA S, OHSAKA A, SAITO M, TAKAKU F. Stimulation and priming of human neutrophils by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: qualitative and quantitative differences. Biochem Biophys Res Commun 1990: 171: 491-497.
5. BERKOW RL, DODSON MR. Biochemical mechanisms involved in the priming of neutrophils by tumor necrosis factor. J Leuk Biol 1988: 44: 345-352.
6. HASLETT C, GUTHRIE LA, KOPANIAK MM, JOHNSTON JR RB, HENSON PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 1985: 119: 101-110.
7. BOXER LA, YODER M, BONSIB S, et al. Effects of a chemotactic factor, N-formyl-methionyl peptide, on adherence, superoxide anion generation, phagocytosis and microtubule assembly of human polymorphonuclear leukocytes. J Lab Clin Med 1979: 93: 506-514.
8. DECHATELET LR, SHIRLEY PS, JOHNSTON JR RB. Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood 1976: 47: 545-554.
9. YOSHIMURA T, MATSUSHIMA K, TANAKA S, et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987: 84: 9233-9237.
10. WEINBLATT ME, COBLYN JS, FOX DA, et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 1985: 312: 818-822.
11. COLLINS P, ROGERS S. The efficacy of methotrexate in psoriasis - a review of 40 cases. Clin Exp Dermatol 1992: 17: 257-260.
12. O'CALLAGHAN JW, FORREST MJ, BROOKS PM. Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients. Rheumatol Int 1988: 8: 41-45.
13. CREAM JJ, POLE DS. The effect of methotrexate and hydroxyurea on neutrophil chemotaxis. Br J Dermatol 1980: 102: 557-563.
14. WEBER GF, NAIR MG, MCCORD JM. The antifolate 10-deazaaminopterin inhibits neutrophil chemotaxis and superoxide generation. Immunopharmacol Immunotoxicol 1991: 13: 379-393.
15. STORGAARD M, JENSEN MP, STENGAARD-PEDERSEN K, MOLLER BK, ANDERSON PL, OBEL N. Effects of methotrexate, sulphasalazine and aurothiomalate on polymorphonuclear leukocytes in rheumatoid arthritis. Scand J Rheumatol 1996: 25: 168-173.
16. OKUDA A, KUBOTA M, SAWADA M, et al. Methotrexate inhibits superoxide production and chemotaxis in neutrophils activated by granulocyte colony-stimulating factor. J Cell Physiol 1996: 168: 183-187.
17. BÖYUM A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest (Suppl) 1968: 97: 77-89.
18. ADACHI S, KUBOTA M, WAKAZONO Y, et al. Mechanism of enhancement of neutrophil survival by granulocyte colony-stimulating factor and adenine. Exp Hematol 1993: 21: 1213-1218.
19. NEWBURGER PE, CHOVANIEC ME, COHEN HJ. Activity and activation of the granulocyte superoxide-generating system. Blood 1980: 55: 85-92.
20. FALK W, GOODWIN JR RH, LEONARD EJ. A 48-well microchemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 1980: 33: 239-247.
21. JOLIVET J, COWAN KH, CURT GA, CLENDENINN NJ, CHABNER BA. The pharmacology and clinical use of methotrexate. N Engl J Med 1983: 309: 1094-1104.
22. HAKALA MT, TAYLOR E. The ability of purine and thymine derivatives and of glycine to support the growth of mammalian cells in culture. J Biol Chem 1959: 234: 126-128.
23. PALLISTER CJ, WARNOCK DW. Effect of antimicrobial and antineoplastic drugs alone and in combination on the phagocytic and candidacidal function of human polymorphonuclear leukocytes. J Antimicrob Chemother 1989: 23: 87-94.
24. SEITZ M, DEWALD B, CESKA M, GERBER N, BAGGIOLINI M. Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol Int 1992: 12: 159-164.
25. SPERLING RI, BENINCASO AI, ANDERSON RJ, COBLYN JS, AUSTEN KF, WEINBLATT ME. Acute and chronic suppression of leukotriene B4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate. Arthritis Rheum 1992: 35: 376-384.
26. NESHER G, MOORE TL, DORNER RW. In vitro effects of methotrexate on peripheral blood monocytes: modulation by folinic acid and S-adenosylmethionine. Ann Rheum Dis 1991: 50: 637-641.
27. BOKOCH GM. Chemoattractant signaling and leukocyte activation. Blood 1995: 86: 1649-1660.
28. HATA Y, NATSUMEDA Y, WEBER G. Tiazofurin decreases Ras-GTP complex in K562 cells. Oncol Res 1993: 5: 161-164.